Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	MDFI	MDFIC MDFI	1.20e-06	2	21	2	PF15316
Domain	MDFI/MDFIC	MDFIC MDFI	1.20e-06	2	21	2	IPR026134
Domain	Growth_fac_rcpt_	FBLN1 PCSK6	1.31e-02	156	21	2	IPR009030
Domain	EGF	FBLN1 PCSK6	2.83e-02	235	21	2	SM00181
Pubmed	Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer.	MDFIC MDFI	1.04e-06	3	21	2	32457453
Pubmed	I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways.	MDFIC MDFI	2.08e-06	4	21	2	12192039
Pubmed	Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.	MDFIC MDFI	2.08e-06	4	21	2	17289077
Pubmed	Myogenic repressor I-mfa interferes with the function of Zic family proteins.	MDFIC MDFI	3.47e-06	5	21	2	15207726
Pubmed	Molecular properties of Zic4 and Zic5 proteins: functional diversity within Zic family.	MDFIC MDFI	5.20e-06	6	21	2	15465018
Pubmed	A transposon in Comt generates mRNA variants and causes widespread expression and behavioral differences among mice.	SLC12A6 SYT1	4.70e-05	17	21	2	20808911
ToppCell	356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|356C / Donor, Lineage, Cell class and subclass (all cells)	SYT1 FBLN1 FGF18 MDFI	1.29e-06	176	21	4	135d51d28a7ad2a67d5a6c49eb6e661f4beb66f5
ToppCell	356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SYT1 FBLN1 FGF18 MDFI	1.29e-06	176	21	4	2287bd8382f41e36ebb0875a0133bada1ec81fa7
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYT1 FBLN1 FGF18 MDFI	1.38e-06	179	21	4	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYT1 FBLN1 FGF18 MDFI	1.50e-06	183	21	4	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYT1 FBLN1 FGF18 MDFI	1.57e-06	185	21	4	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYT1 ADCY2 FBLN1 FGF18	1.74e-06	190	21	4	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYT1 ADCY2 FBLN1 FGF18	1.74e-06	190	21	4	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SYT1 FBLN1 FGF18 MDFI	1.82e-06	192	21	4	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYT1 ADCY2 FBLN1 FGF18	1.93e-06	195	21	4	c6bb16c0076639c6ddef1a15d8cba44bc29c077d
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYT1 ADCY2 FBLN1 FGF18	1.93e-06	195	21	4	ea89f80d3d7e9f737442f7c1aa1791d277ffc90c
ToppCell	15-Distal-Mesenchymal-Airway_Smooth_Muscle\|Distal / Age, Tissue, Lineage and Cell class	SYT1 FBLN1 FGF18 MDFI	1.97e-06	196	21	4	0e45817625b96d21a8cc4dfbbd465ee6403b6802
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNFRSF13B SYT1 NLRP4	5.81e-05	162	21	3	b46158e260bd2f35702cec73e3b035e8e9ec4469
ToppCell	10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive\|bone_marrow / Manually curated celltypes from each tissue	TNFRSF13B SYT1 NLRP4	5.81e-05	162	21	3	44832055b11a789e320c802aadb345e065defc8f
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SYT1 ADCY2 PAQR3	6.03e-05	164	21	3	583dda853cee9491dbdcb228c23d8deadc20eb08
ToppCell	Basal_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	ADCY2 FBLN1 MDFI	6.25e-05	166	21	3	23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b
ToppCell	COVID-19-Heart-Lymph_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRE SYT1 SLC22A23	7.56e-05	177	21	3	326fde0734ef0d7272693966d346ca479b9d8147
ToppCell	COVID-19-kidney-Stressed_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRE SLC22A23 PCSK6	7.81e-05	179	21	3	754f69bac7a1d5137f5141f6193285ccbfe361cb
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRE SLC22A23 PCSK6	7.94e-05	180	21	3	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYT1 ADCY2 FBLN1	7.94e-05	180	21	3	c2746092ef251e9d5910fe96461afdd0624a24c6
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYT1 ADCY2 FBLN1	7.94e-05	180	21	3	32c6a3886428d82fb4355d987c6d2645f333447b
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FGF18 PCSK6	8.34e-05	183	21	3	5cfcd589a480e67654d3d94e71916f122150db10
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FGF18 PCSK6	8.34e-05	183	21	3	c3ea8d3b916ffcaca3156e0d77a952724554c4ab
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FGF18 PCSK6	8.34e-05	183	21	3	81003ddc24164959dd41bb12fcac72638789b8f2
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYT1 FBLN1 MDFI	8.34e-05	183	21	3	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DNAJC5G MDFIC SLC22A23	8.48e-05	184	21	3	3b0389c3a5a16697de860e98ebc48ed39ede646f
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 FGF18 PCSK6	8.48e-05	184	21	3	d754c3de621429b220ae4ac426cdfc619e848462
ToppCell	droplet-Marrow-nan-21m-Hematologic-hematopoietic_precursor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2A SHISA5 MDFI	8.48e-05	184	21	3	7e129862f8d2353387999e633725325c4d8cb42e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYT1 FBLN1 FGF18	8.61e-05	185	21	3	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	Control-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	FBLN1 FGF18 MDFI	8.61e-05	185	21	3	d5d6d13e2f20b54ca55645b9a757b8599f4fd897
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRE SLC22A23 PCSK6	8.61e-05	185	21	3	673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FGF18 PCSK6	8.75e-05	186	21	3	a7ab70b049742dfe7ee30557031bfac6412edf52
ToppCell	facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC12A6 TNFRSF13B FBLN1	8.89e-05	187	21	3	b51af2824e65734f333b1325117f4a2e88b17c23
ToppCell	facs-Spleen-nan-3m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC12A6 TNFRSF13B FBLN1	8.89e-05	187	21	3	3ca3954f45f167e98a230f2847f0582d74fcd32e
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GABRE SYT1 FGF18	9.03e-05	188	21	3	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYT1 FBLN1 FGF18	9.18e-05	189	21	3	cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYT1 FBLN1 FGF18	9.18e-05	189	21	3	102501eee7760d5882dec41ea9d00147b3f4fb73
ToppCell	droplet-Lung-21m-Mesenchymal-myofibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYT1 FBLN1 FGF18	9.18e-05	189	21	3	6e83bf855d4771885b60bb8992df2f9b508eef97
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 FBLN1 FGF18	9.32e-05	190	21	3	f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a
ToppCell	droplet-Kidney-nan-3m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 FBLN1 FGF18	9.32e-05	190	21	3	2abeb013bb83c578e67dcb985ba44ca63134950b
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC12A6 TNFRSF13B SHISA5	9.32e-05	190	21	3	ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SYT1 FBLN1 MDFI	9.32e-05	190	21	3	71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYT1 ADCY2 FGF18	9.47e-05	191	21	3	fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	FBLN1 SLC22A23 MDFI	9.47e-05	191	21	3	e4c1c533771b582e21683dbec6f93a558d865e00
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRE SLC22A23 PCSK6	9.47e-05	191	21	3	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SYT1 FBLN1 FGF18	9.47e-05	191	21	3	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	FBLN1 SLC22A23 MDFI	9.47e-05	191	21	3	48cffb55c71bb8b34e926fc461fcd345ce43ea00
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 FBLN1 FGF18	9.47e-05	191	21	3	d1205aab0937f2becfcd239610e9b78fb8a0c886
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DMRTC2 FBLN1 MDFI	9.62e-05	192	21	3	f053b89bfd6048c227667ff01c38df7c51d8a496
ToppCell	droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYT1 FBLN1 FGF18	9.76e-05	193	21	3	2b80991e7ba7640f7ab2139d30e4c54d8e533862
ToppCell	droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYT1 FBLN1 FGF18	9.76e-05	193	21	3	90cfc34c2d0d7c70f071703d35db1d6037961481
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	GABRE SLC22A23 PCSK6	9.76e-05	193	21	3	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SYT1 FGF18 MDFI	9.76e-05	193	21	3	2f203f6f0c2135acb046c9351a633c3b5b254a46
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SYT1 FBLN1 MDFI	9.76e-05	193	21	3	e2b455387d1de7812305200a2041a0f4759a6f54
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like-IPCs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	FBLN1 SLC22A23 MDFI	9.91e-05	194	21	3	2378a98452f6ec33870eeb994b8b812e9b507f4c
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SYT1 FBLN1 MDFI	9.91e-05	194	21	3	fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c
ToppCell	P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SYT1 FBLN1 FGF18	9.91e-05	194	21	3	3c661c6768c3f05d2aba03d329adb257ca201b2d
ToppCell	facs-Heart-RA-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 FGF18 PCSK6	9.91e-05	194	21	3	bc945450b350f597c3ff910d3a14a533d90086a8
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	FBLN1 SLC22A23 MDFI	9.91e-05	194	21	3	7ba0445a486feac18b3a4fd6f2855c102e374e2d
ToppCell	P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SYT1 FBLN1 FGF18	9.91e-05	194	21	3	5f04d21c4e2d36e74b6c5889aa97fd98f75a0973
ToppCell	NS-critical-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRE FBLN1 TMEM92	1.04e-04	197	21	3	a72047b7428c0d4aaf016c1ac23dc30919260fd8
ToppCell	distal-1-mesenchymal-Myofibroblast\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FBLN1 FGF18 MDFI	1.07e-04	199	21	3	58c36f5a30c6862b7f5587a0b9bc31da99e43dd5
ToppCell	distal-3-mesenchymal-Myofibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FBLN1 FGF18 MDFI	1.07e-04	199	21	3	1f20addc0d138fec02ed6ca4c518169c568de263
ToppCell	medial-mesenchymal-Myofibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FBLN1 FGF18 MDFI	1.07e-04	199	21	3	e25acdb5809aaff631cb06dbe4c7e59549a0bdb9
ToppCell	medial-2-mesenchymal-Myofibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FBLN1 FGF18 MDFI	1.07e-04	199	21	3	95aae608fa35a9c82b12c6f18937ce636750ca44
ToppCell	medial-mesenchymal-Myofibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FBLN1 FGF18 MDFI	1.07e-04	199	21	3	9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d
ToppCell	distal-mesenchymal-Myofibroblast-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FBLN1 FGF18 MDFI	1.08e-04	200	21	3	069c8949b33ecfdb6da32992002d4060ff6082bc
ToppCell	distal-mesenchymal-Myofibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FBLN1 FGF18 MDFI	1.08e-04	200	21	3	61854a459385cd9295be37157a8f81a2c227dff3
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DNAJC5G FGF18	4.37e-04	66	21	2	88afd3ab91774ce01ff4277395b7b59dbb23200a
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADORA2A RTP3	7.41e-04	86	21	2	d20ec61a572b11641647358a546334b217c694f3
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp-Endothelial_Tip.Dcn.Mgp-Penk_(Penk)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	GABRE DMRTC2	8.84e-04	94	21	2	8fb9adf0db3b0007204716869d895700cbdc6231
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal-Cortical_neuron\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	SYT1 SHISA5	8.84e-04	94	21	2	a752c80fb2e83cffa22a00d7e98c24406ee41908
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ADORA2A HSD17B3	1.02e-03	101	21	2	6523c314166dcf66c3ed13c02ca4b886b068e5b8
ToppCell	LA-04._Ventricular_Cardiomyocyte_I\|LA / Chamber and Cluster_Paper	DNAJC5G DMRTC2	1.21e-03	110	21	2	34dcd1e1e16e8b6088ff9a7a40532e8bd000c121
ToppCell	Globus_pallidus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TNFRSF13B MDFI	1.25e-03	112	21	2	df524107893efb96ac29b823a3568c6b2602c00a
ToppCell	Globus_pallidus-Hematopoietic-MICROGLIA-MI2(C1qb)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TNFRSF13B MDFI	1.25e-03	112	21	2	2378da89ce8db96615763728801e1d1320ffd14a
ToppCell	Globus_pallidus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TNFRSF13B MDFI	1.25e-03	112	21	2	f206acd2c785dd132c6c122466cfdb3cde443caa
ToppCell	Globus_pallidus-Hematopoietic-MICROGLIA\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TNFRSF13B MDFI	1.25e-03	112	21	2	ecda7c1c1c6df419cc48cd4f04acb9dfbc6f69f7
ToppCell	Globus_pallidus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TNFRSF13B MDFI	1.25e-03	112	21	2	73248a855b644385ed6670a72f10b1d9e4371de9
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	GABRE ADORA2A	1.39e-03	118	21	2	3cebd17f4688cd43fe1283dc60957e87d5536810
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	GABRE ADORA2A	1.39e-03	118	21	2	71f63efc641cd07c870f7695118fb244929c1536
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	GABRE ADORA2A	1.39e-03	118	21	2	61b00b001edb1954a5fffaf4dfe71708124a45e5
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DMRTC2 MDFI	1.53e-03	124	21	2	b0ed84522180f8cea541461faf7882c57abf8cd4
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DMRTC2 MDFI	1.53e-03	124	21	2	231862f849d8ab73c6a44c782d33ef2f07661baf
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Abcc9_(Mural.Acta2Rgs5.Abcc9)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ADORA2A MDFIC	1.58e-03	126	21	2	43e7b226a195ab2068518b3a9ffd2192129e8ae4
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Abcc9_(Mural.Acta2Rgs5.Abcc9)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ADORA2A MDFIC	1.58e-03	126	21	2	2b06adfb00a557bd90ad93719548a49f9ae9edeb
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TNFRSF13B TMEM92	1.65e-03	129	21	2	58790c6eaa597b8e8209a0fbc970e9cffa10bca5
ToppCell	TCGA-Brain-Recurrent_Tumor-Glioblastoma-Primary_GBM-8\|TCGA-Brain / Sample_Type by Project: Shred V9	RTP3 TMEM92	1.73e-03	132	21	2	614903874a5304b718737cfb9d86b420592ce271
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SYT1 FGF18	1.73e-03	132	21	2	9633653dba1edee47d915212fb6e68426da49de5
ToppCell	Mild/Remission-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SYT1 PCSK6	1.83e-03	136	21	2	1b3c6edcbe0eb674d2d9c838e83ebe2b93e3eec1
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	DNAJC5G GABRE	1.86e-03	137	21	2	b553958e7e6dcd887d860e34d3983cbb85cefaa6
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 PCSK6	1.89e-03	138	21	2	d5342383c5e52b92c39d7afe76560501be3ea5cd
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 PCSK6	1.89e-03	138	21	2	e2659949944bdf39b23c7275e380a7a937e2726c
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	SYT1 TMEM92	2.00e-03	142	21	2	43524c10f446c9da079cff52800326a1d4675452
ToppCell	P03-Hematopoietic-Erythroid\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TNFRSF13B RTP3	2.05e-03	144	21	2	2ee6a834860eac7ed004f366ab4fc38c4b80c905
ToppCell	P03-Hematopoietic-Erythroid-enucleate_erythrocyte\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TNFRSF13B RTP3	2.05e-03	144	21	2	9fa63904389f4d7163db22ea85ab721d8f6e8d99
ToppCell	COVID-19-kidney-Mito-rich_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRE SLC22A23	2.08e-03	145	21	2	afed661aef990edb8e7012ab67ace56443520c9f
ToppCell	Bronchus_Control_(B.)-Immune-TX-TRAM-3\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	TNFRSF13B SYT1	2.14e-03	147	21	2	50a855aa7f214c3be8ac46a22adf9bc9dd0285db
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSD17B3 TMEM92	2.14e-03	147	21	2	f703cb0330304799d16e457215269c7732c9d5d5
ToppCell	COVID-19-kidney-Lymphatic_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC22A23 PCSK6	2.17e-03	148	21	2	f777aa1674e898e2594b2b7c029d3d05dda04df9
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TNFRSF13B SYT1	2.17e-03	148	21	2	6ffa212f0cc44c40d2143816dc6cfd82fbf09a33
Drug	diazepam	GABRE ADORA2A ADCY2 MDFIC	2.46e-05	189	21	4	CID000003016
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	ADORA2A TNFRSF13B FBLN1 PCSK6	2.73e-05	194	21	4	3363_UP
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A	ADORA2A TNFRSF13B FBLN1 PCSK6	2.84e-05	196	21	4	6782_UP
Drug	CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A	FBLN1 PCSK6 MDFI HSD17B3	2.90e-05	197	21	4	6412_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; HL60; HT_HG-U133A	SYT1 MDFIC FGF18 PCSK6	2.96e-05	198	21	4	2554_UP
Drug	Ketoprofen [22071-15-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ADORA2A FBLN1 FGF18 PCSK6	2.96e-05	198	21	4	4751_UP
Drug	Fipexide hydrochloride [34161-23-4]; Up 200; 9.4uM; PC3; HT_HG-U133A	GABRE FBLN1 FGF18 PCSK6	3.08e-05	200	21	4	5737_UP
Drug	propyl	ADORA2A NLRP4 MDFIC	3.71e-05	71	21	3	CID000123145
Drug	terbutaline	SLC12A6 ADORA2A ADCY2	5.31e-05	80	21	3	CID000005403
Drug	pentylenetetrazol	GABRE ADORA2A MDFIC	2.24e-04	130	21	3	CID000005917
Drug	2-deoxyadenosine	ADORA2A NLRP4 ADCY2	2.40e-04	133	21	3	CID000000636
Drug	PD 81,723	ADORA2A ADCY2	2.40e-04	25	21	2	CID000122028
Drug	clenbuterol	ADCY2 MDFIC MDFI	2.91e-04	142	21	3	CID000002783
Drug	d-dm	ADORA2A SYT1	5.29e-04	37	21	2	CID000007576
Drug	SKF 82958	ADORA2A SYT1	5.88e-04	39	21	2	CID000001225
Drug	Isoconazole [27523-40-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ADORA2A FGF18 HSD17B3	6.50e-04	187	21	3	7211_UP
Drug	baclofen	GABRE ADORA2A ADCY2	6.91e-04	191	21	3	CID000002284
Drug	Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ADORA2A TNFRSF13B ADCY2	6.91e-04	191	21	3	3392_UP
Drug	Avermectin B1 [71751-41-2]; Up 200; 4.8uM; MCF7; HT_HG-U133A	SLC12A6 FGF18 HSD17B3	7.02e-04	192	21	3	7218_UP
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	SLC12A6 FBLN1 PCSK6	7.13e-04	193	21	3	3627_DN
Drug	Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A	ADORA2A ADCY2 PCSK6	7.13e-04	193	21	3	3880_UP
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ADCY2 FGF18 MDFI	7.23e-04	194	21	3	5695_UP
Drug	Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	TNFRSF13B FBLN1 PCSK6	7.34e-04	195	21	3	2225_UP
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A	ADORA2A ADCY2 PCSK6	7.45e-04	196	21	3	5488_UP
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	TNFRSF13B FBLN1 PCSK6	7.45e-04	196	21	3	2198_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A	SLC12A6 FBLN1 PCSK6	7.45e-04	196	21	3	3965_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A	TNFRSF13B FBLN1 PCSK6	7.45e-04	196	21	3	2270_UP
Drug	Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A	TNFRSF13B FBLN1 PCSK6	7.45e-04	196	21	3	3849_DN
Drug	Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A	ADORA2A FBLN1 PCSK6	7.45e-04	196	21	3	4151_DN
Drug	Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ADORA2A TNFRSF13B PCSK6	7.45e-04	196	21	3	2876_UP
Drug	Josamycin [16846-24-5]; Up 200; 4.8uM; MCF7; HT_HG-U133A	ADORA2A PCSK6 MDFI	7.45e-04	196	21	3	5692_UP
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A	SYT1 FBLN1 MDFI	7.45e-04	196	21	3	6602_DN
Drug	Benzbromarone [3562-84-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	TNFRSF13B FBLN1 MDFI	7.45e-04	196	21	3	6669_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; PC3; HT_HG-U133A	ADORA2A FGF18 PCSK6	7.45e-04	196	21	3	4564_UP
Drug	radicicol; Down 200; 0.1uM; MCF7; HG-U133A	ADORA2A PCSK6 HSD17B3	7.45e-04	196	21	3	325_DN
Drug	lorazepam	GABRE MDFIC	7.49e-04	44	21	2	CID000003958
Drug	Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A	TNFRSF13B FBLN1 FGF18	7.56e-04	197	21	3	3881_UP
Drug	Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A	FBLN1 FGF18 PCSK6	7.56e-04	197	21	3	5616_UP
Drug	CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A	SLC12A6 ADORA2A FBLN1	7.56e-04	197	21	3	7486_DN
Drug	Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A	TNFRSF13B FGF18 PCSK6	7.56e-04	197	21	3	5664_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	ADORA2A TNFRSF13B FBLN1	7.56e-04	197	21	3	3837_DN
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A	FBLN1 FGF18 PCSK6	7.56e-04	197	21	3	2822_DN
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; HL60; HT_HG-U133A	TNFRSF13B SYT1 FBLN1	7.56e-04	197	21	3	3008_UP
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A	ADORA2A ADCY2 FBLN1	7.56e-04	197	21	3	5565_UP
Drug	Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ADCY2 FBLN1 MDFI	7.56e-04	197	21	3	3390_UP
Drug	Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A	ADCY2 PCSK6 MDFI	7.56e-04	197	21	3	3234_UP
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	SLC12A6 FBLN1 MDFIC	7.56e-04	197	21	3	2126_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A	SLC12A6 PCSK6 MDFI	7.56e-04	197	21	3	2751_UP
Drug	Clopamide [636-54-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	FGF18 PCSK6 MDFI	7.56e-04	197	21	3	5402_UP
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; HL60; HT_HG-U133A	SYT1 PCSK6 MDFI	7.56e-04	197	21	3	2435_UP
Drug	Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A	FBLN1 FGF18 PCSK6	7.68e-04	198	21	3	5272_UP
Drug	phenformin hydrochloride; Down 200; 10uM; MCF7; HG-U133A	TNFRSF13B FBLN1 HSD17B3	7.68e-04	198	21	3	21_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; MCF7; HT_HG-U133A	ADORA2A FBLN1 PCSK6	7.68e-04	198	21	3	3304_DN
Drug	Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SLC12A6 FBLN1 PCSK6	7.68e-04	198	21	3	4414_DN
Drug	Oxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A	TNFRSF13B ADCY2 MDFI	7.68e-04	198	21	3	4530_UP
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	TNFRSF13B FBLN1 HSD17B3	7.68e-04	198	21	3	2286_UP
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	SLC12A6 ADORA2A FBLN1	7.68e-04	198	21	3	3326_DN
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	FBLN1 MDFIC PCSK6	7.68e-04	198	21	3	2200_DN
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; PC3; HT_HG-U133A	SYT1 MDFIC MDFI	7.68e-04	198	21	3	4579_DN
Drug	Flutamide [13311-84-7]; Up 200; 14.4uM; HL60; HT_HG-U133A	FBLN1 MDFIC PCSK6	7.68e-04	198	21	3	2358_UP
Drug	Ginkgolide A [15291-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ADORA2A TNFRSF13B PCSK6	7.68e-04	198	21	3	3260_UP
Drug	Rolipram [61413-54-5]; Down 200; 14.6uM; HL60; HT_HG-U133A	ADORA2A TNFRSF13B FBLN1	7.68e-04	198	21	3	3072_DN
Drug	0225151-0000 [351320-15-5]; Down 200; 10uM; MCF7; HT_HG-U133A	ADORA2A ADCY2 FBLN1	7.68e-04	198	21	3	6384_DN
Drug	Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A	ADCY2 FGF18 PCSK6	7.68e-04	198	21	3	3713_UP
Drug	Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	ADORA2A FGF18 PCSK6	7.68e-04	198	21	3	4235_UP
Drug	Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; PC3; HT_HG-U133A	FGF18 PCSK6 MDFI	7.68e-04	198	21	3	4608_UP
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; PC3; HT_HG-U133A	SYT1 FBLN1 MDFI	7.68e-04	198	21	3	4479_DN
Drug	Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A	TNFRSF13B FBLN1 FGF18	7.79e-04	199	21	3	3565_UP
Drug	Ronidazole [7681-76-7]; Down 200; 20uM; HL60; HT_HG-U133A	SLC12A6 FBLN1 PCSK6	7.79e-04	199	21	3	6134_DN
Drug	Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A	TNFRSF13B FBLN1 MDFI	7.79e-04	199	21	3	2257_UP
Drug	Norfloxacin [70458-96-7]; Up 200; 12.6uM; HL60; HG-U133A	TNFRSF13B PAQR3 PCSK6	7.79e-04	199	21	3	1406_UP
Drug	clozapine; Up 200; 10uM; MCF7; HG-U133A	TNFRSF13B FGF18 HSD17B3	7.79e-04	199	21	3	416_UP
Drug	Milrinone [78415-72-2]; Up 200; 19uM; MCF7; HT_HG-U133A	ADORA2A FGF18 MDFI	7.79e-04	199	21	3	3552_UP
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A	SLC12A6 FBLN1 PCSK6	7.79e-04	199	21	3	5516_UP
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	TNFRSF13B PCSK6 MDFI	7.79e-04	199	21	3	6804_UP
Drug	Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	ADORA2A TNFRSF13B FBLN1	7.79e-04	199	21	3	2289_UP
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; PC3; HT_HG-U133A	TNFRSF13B MDFIC MDFI	7.79e-04	199	21	3	6640_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A	SYT1 FBLN1 MDFIC	7.79e-04	199	21	3	5787_DN
Drug	Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A	ADORA2A TNFRSF13B PCSK6	7.79e-04	199	21	3	6515_UP
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A	SLC12A6 FGF18 PCSK6	7.79e-04	199	21	3	4775_UP
Drug	Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; HL60; HG-U133A	TNFRSF13B SYT1 PCSK6	7.90e-04	200	21	3	1443_UP
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; PC3; HT_HG-U133A	TNFRSF13B ADCY2 FBLN1	7.90e-04	200	21	3	6333_UP
Drug	Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A	SLC12A6 PCSK6 MDFI	7.90e-04	200	21	3	5432_UP
Drug	Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	TNFRSF13B MDFIC PCSK6	7.90e-04	200	21	3	4170_UP
Drug	ethanol	GABRE ADORA2A SYT1 ADCY2 MDFIC	8.26e-04	837	21	5	CID000000702
Drug	Octa	FGF18 PCSK6	8.91e-04	48	21	2	CID000010213
Disease	sodium measurement	TNFRSF13B SYT1	1.99e-03	103	19	2	EFO_0009282
Disease	neuroticism measurement, cognitive function measurement	SYT1 ADCY2 SLC22A23	5.41e-03	566	19	3	EFO_0007660, EFO_0008354

Protein segments in the cluster

Peptide	Gene	Start	Entry
CAACHGCLFIACFVL	ADORA2A	71	P29274
VICSICLFCFQVCML	PAQR3	106	Q6TCH7
CCVHCILACLFCEFL	MDFIC	166	Q9P1T7
LCERKLFIQFCCRTC	PCSK6	951	P29122
SACTCLCLHFLLLCF	FGF18	6	O76093
ICFVFCFCALLEFAV	GABRE	346	P78334
CCLDSLCLVKCFITA	NLRP4	836	Q96MN2
LEATFVKRCCHCCLL	FBLN1	101	P23142
TLVILCTLLTCCCFC	DNAJC5G	126	Q8N7S2
CACLIFFCIFIVQIL	ADCY2	606	Q08462
NLFCCLLFSMCNLFC	GIMAP2	296	Q9UG22
CLFQACECHKCVLIL	DMRTC2	61	Q8IXT2
HCILSCLFCEFLTLC	MDFI	166	Q99750
VCLACLAKCVRFSRC	HSD17B3	16	P37058
GVLQAFAIVLICCCC	SLC12A6	216	Q9UHW9
FAIVLICCCCTMLTA	SLC12A6	221	Q9UHW9
HICRNLSIFCCCVIL	RTP3	206	Q9BQQ7
IVAVLLVLTCCFCIC	SYT1	66	P21579
HIIFACCTLICIICI	SLC22A23	601	A1A5C7
VVTIIICFTCSCCCL	SHISA5	121	Q8N114
ILSVFCICGLAKCFC	TMEM92	66	Q6UXU6
LCAVLCCFLVAVACF	TNFRSF13B	171	O14836